A health-system-scale, episode-resolved multimodal atlas of cancer cachexia
Castillon, V. J.; Xie, A.; Boscenco, S.; Tse, E.; Ruthen, N.; Wang, J.; El Bakouny, Z.; Waters, M.; Fu, C.; Fong, C.; Shah, U. A.; Hakimi, A. A.; Jee, J.; White, E.; Janowitz, T.; Goncalves, M.; Reznik, E.
Show abstract
Cancer cachexia is a wasting syndrome with outsized impact on morbidity and mortality. Neither the etiology of cachexia, nor its consequences on patient physiology and outcomes, are well-understood. Here, we repurposed longitudinal clinicogenomic data from 59,493 cancer patients to define episode-resolved trajectories of cachexia and linked them to serology, tumor genotypes, and clinical outcomes. Cachexia risk concentrated around periods of disease progression and associated with inferior outcomes in nearly all cancer types. Across cancers, cachectic episodes exhibited a consistent serologic signature characterized by low albumin and hemoglobin and high levels of liver enzymes. Numerous somatic tumor genotypes, including TP53 mutation across several diseases, were associated with elevated cachexia risk. Motivated by these observations, we developed a multivariate model to predict impending risk of cachexia in lung and colorectal cancer patients. Routine clinicogenomic data is therefore a powerful resource for discovery in cachexia and other cancer-associated pathophysiologies.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Single-cell integration and multi-modal profiling reveals phenotypes and spatial organization of neutrophils in colorectal cancer 95%
- B3GALT6 Promotes Dormant Breast Cancer Cell Survival and Recurrence by Enabling Heparan Sulfate-Mediated FGF Signaling 95%
- An mRNA-encoded, long-lasting Interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers 94%
Similar papers in this journal
Similar papers in this journal
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 95%
- Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma 94%
- Developmental priming of cancer susceptibility 94%
Similar papers in this journal
- Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors 95%
- Genome-wide identification and analysis of prognostic features in human cancers 95%
- Identifying a gene signature of metastatic potential by linking pre-metastatic state to ultimate metastatic fate 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.